Table 5.
Base case (dis-)utility values for the Markov model health states (more than 90 days after surgery).
| Mean (dis-)utility | SE(a) | Source | duration | |
|---|---|---|---|---|
| Post stroke (disabled) | −10% | Lunde 2013 (Board NE, 2017) 345 Stroke patients in Norway who had ischaemic/haemorrhagic or TIA | lifetime | |
| Mild to Moderate PTS | −0.02 | Lenert 1997 (Annemans et al., 2004) | lifetime | |
| Severe PTS | −0.07 | Lenert 1997 (Annemans et al., 2004) | lifetime | |
| CTEPH-Year 1 | −26% | Meads 2008 (Bischof et al., 2006) | Operable or inoperable (3 months) Recurrent/resistant (12 months) | |
| CTEPH - Year 2- recurrent resistantChronic CTEPH | 22% | Meads 2008 (Bischof et al., 2006) | Utility improvement after medical treatment applied to CTEPH-Year 1 utility value Chronic CTEPH utility applied lifetime | |
| Post-HIT amputation | −0.28 | Beaudet 2014 (Dahl et al., 2010), T1D GL (Bjorvatn and Kristiansen, 2005) | Lifetime |
HIT, heparin-induced thrombocytopaenia; SE, standard error; T1D, Type 1 diabetes.
a Where not reported; SE was calculated as 10% of the mean.